期刊文献+

妇科肿瘤调强放疗摆位方法和误差分析及与体重指数的关系 被引量:12

Positioning method and relationship with setup errors and BMI in the patients treated with intensity-modulated radiation therapy for gynecological malignancies
下载PDF
导出
摘要 目的:盆腔调强放疗计划会在肿瘤靶区周围产生剂量的梯度陡降,因此对患者的精确摆位至关重要。摆位误差一旦超可控范围,肿瘤靶区周围的正常组织将受不必要的照射。本文为量化放疗摆位方法的科学性,并且讨论体重指数对摆位误差的影响。方法:对我科2014年1~6月通过盆腔调强放疗治疗的35名妇科肿瘤患者分别进行多组CT图像的采集,获得患者在RL(左右),SI(头脚)和AP(腹背)方向的偏移数据,从而计算出摆位误差,验证摆位方法。同时,我们通过多次测算每个患者体重指数,将其平均值与其个体误差数据进行比对,了解体重、身高等因素对摆位误差的影响。结果:系统误差在RL、SI和AP方向分别为2.1、2.4和3.0 mm,随机误差在RL、SI和AP方向分别为2.8、2.6和3.5 mm。结论:肯定了摆位方法的科学合理,确定了CTV到PTV的外扩边界大小,患者摆位误差与体重指数并无相关性。 Objective: Intensity-modulated whole dose gradients around the target volume, and thus pelvic radiation therapy (IM-WPRT) plans result in steep accurate patient setup is essential. We will quantify the accuracy of our patient positioning, and discuss the effect of body mass index of setup error. Methods: We examined the CT images of 35 women treated with IM-WPRT at our institution, get the data in three directions (RL,SI and AP),and calculate the setup error in patients treated with IM-WPRT to verify patient positioning. Calculating the average of body mass index (BMI), we find there is a relationship between the setup error and BMI. Results: In three directions(RL,SI and AP), the systematic error is 2.1 mm,2.4 mm and 3.0 mm, and the random error is 2.8 mm,2.6 mm and 3.5 mm. Conclusion: Determine the CTV to PTV outside enlarge border size, we make the IM-WPRT plan more scientific. There was no correlation between the magnitude of these errors and the BMI. K
出处 《泸州医学院学报》 2015年第5期498-501,共4页 Journal of Luzhou Medical College
关键词 妇科肿瘤 调强放疗 摆位方法 误差 体重指数 Gynecological malignancies IMRT Positioning method Setup errors BMI
  • 相关文献

参考文献13

  • 1Mundt AJ,Roeske JC,LuJan AJ,et al.Initial clinical experience with intensity-modulated whole-pelvis radia-tion therapy in women with gynecologic malignancies[J].Gynecol Oncol,2001,82:456-463.
  • 2Roeske JC,LuJan AE,Rotmensch J,et al.Intensity-modulated whole pelvic radiation therapy in patients with gynecological malignancies[J].Int Radiat Oncol Biol Phys,2000,48:1613-1621.
  • 3Mundt AJ,Roeske JC,LuJan AE.Intensity-modulated radiation therapy in gynecologic malignancies[J].Med Dosim,2002,27:131-136.
  • 4Brixey CJ,Roeske JC,LuJan AE,et al.Impact of intensitymodulated radiotherapy on acute hematologic toxicity in womenwith gynecologic malignancies[J].Int Radiat Oncol Biol Phys,2002,54:1388-1396.
  • 5LuJan AE,Mundt AJ,Yamada SD,et al.Intensitymodul-ated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy[J].Int Radiat Oncol Biol Phys,2003,57:516-521.
  • 6Keys A,Fidanza F,Karvonen MJ,et al.Indices of relative weight and obesity[J].J Chron Dis,1972,25:329-343.
  • 7中华人民共和国国家卫生与计划生育委员会.成人体重判定[M].北京:中国标准出版社,2013.
  • 8BiJhold J,Lebesque JV,Hart AA,et al.Maximizing setup accuracy using portal images as applied to a conformal boost technique for prostatic cancer[J].Radiother Oncol,1992,4:261-271.
  • 9RemeiJer P,Geerlof E,Ploeger L,et al.3-D portal image analysis in clinical practice:an evaluation of 2-D and 3-D analysis techniques as applied to 30 prostate cancer patients[J].Int J Radiat Oncol Biol Phys,2000,46:1281-1290.
  • 10Weiss E,Vorwerk H,Richter S,et al.Interfractional and intrafractional accuracy during radiotherapy of gyneco-logical carcinomas:a comprehensive evaluation using the exactrac system[J].Int J Radiat Oncol Biol Phys,2003,56:69-79.

二级参考文献20

  • 1Mell LK, Roeske JC, Mundt AJ. A survey of intensity modulated radiation therapy use in the United States. Cancer,2003,98:204- 211.
  • 2Roeske JC, Lujan A, Rotmensch J, et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys ,2000 ,48 :1613-1621.
  • 3Mell LK, Tiryaki H, Ahn KH, et al. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys,2008,71:1504-1510.
  • 4Chen MF, Tseng C J, Tseng CC, et al. Clinical outcome in post hysterectomy cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys, 2007,67 : 1438-1444.
  • 5Chan P, Dinniwell R, Haider MA, et al. Inter-and intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy: a cinematic-MRI point-of-interest study. Int J Radiat Oncol Biol Phys ,2008,70 : 1507-1515.
  • 6van de Bunt L, van der Heide UA, Ketelaars M, et al. Conventional, eonformal and Intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer:the impact of tumor regression. Int J Radiat Oncol Biol Phys, 2006,64 : 189-196.
  • 7Jhingran A, Salehpour M, Sam M, et al. Vaginal motion and bladder and rectal volumes during pelvic intensity-modulated radiation therapy after hysterectomy. Int J Radiat Oncol Biol Phys, 2011, In Press.
  • 8Raaymakers BW, Lagendijk JJ, Overweg J, et al. Integrating a 1.5 TMRI scanner with a 6 MV accelerator:proof of concept. Phys Med Biol,2009,54:229-237.
  • 9Mell LK, Roeske JC, Mundt A J, et al. A survey of intensity modulated radiation therapy use in the United States. Cancer, 2003,98:204-211.
  • 10Roeske JC, Lujan A, Rotmensch J, et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys,2000,48:1613-1621.

共引文献45

同被引文献95

引证文献12

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部